Latest Lovenox news
Fewer Major Bleeds With Once- Versus Twice-Daily Enoxaparin
posted February 6th
by modernClinician Editorial Team
by modernClinician Editorial Team
Once-daily enoxaparin is associated with fewer major bleeds than enoxaparin twice daily in patients with acute venous thromboembolism, according to a study published online Jan. 25 in the Journal of Thrombosis and Haemostasis.
Editor's Recommendations
New Guideline Details Diagnosis, Treatment of Acute Pulmonary Embolism .jpg)
Guideline Updated for Early Management of Acute Ischemic Stroke 
Continuing Oral Anticoagulants After ≥90 Days Tied to Lower Risk for Recurrent VTE 
Risks for Vascular, Inflammatory Diseases Increased for Children After COVID-19 Related Articles
Safety Intervention Reduces Incidence of Postoperative Endophthalmitis 
Exacerbation Risk Profiles Vary With House Dust Mite Sensitization in Pediatric Asthma 
Early-Life PFAS Exposure Tied to Intestinal Inflammation in Childhood 
Ultra-Endurance Running Accelerates Red Blood Cell Aging Monthly Specialist Briefings
Stay Connected
